35.26 USD
↗ 1.17 (3.43%)AT CLOSE (11:59 AM EDT)
Celldex Therapeutics, Inc
CLDXNASDAQ • USD
32.89
↘ 2.37 (6.72%)
POST MARKET (AS OF 04:41 PM EDT)
Post Market
AS OF 04:41 PM EDT
32.89
↘ 2.37 (6.72%)
Market: CLOSED
Shares of Celldex Therapeutics, Inc (CLDX) are trading at $35.26. CLDX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$34.06
High?$35.47
Low?$33.77
Prev. Close?$34.09
Volume?4.8M
Avg. Volume?1.0M
VWAP?$34.68
Rel. Volume?4.71x
Bid / Ask
Bid?$29.40 × 100
Ask?$35.06 × 700
Spread?$5.66
Midpoint?$32.23
Valuation & Ratios
Market Cap?2.8B
Shares Out?78.5M
Float?70.9M
Float %?90.3%
P/E Ratio?N/A
P/B Ratio?6.07
EPS?-$3.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Employees
198
Market Cap
2.7B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
1986-05-15
Address
53 FRONTAGE ROAD
HAMPTON, NJ 08827
Phone: 908-200-7500
HAMPTON, NJ 08827
Phone: 908-200-7500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?18
Short Sent.?34
Piotroski F-Score?1/9Weak
Altman Z-Score?23.96Safe
Confidence?55%Low
Short InterestHigh
Short % of Float?10.29%High
Short Interest?7.3M
Days to Cover?9.1
Free Float70.9M
Avg Daily Volume805.8K
Settlement Date2026-06-15
Financial Health
Current Ratio?8.92Strong
Quick Ratio?8.92Strong
Cash Ratio?0.69Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.07FAIR▾
Peers100
S&P30
P/S?3,195.88HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-8.9CHEAP▾
S&P97
EV/Sales?3,154.62HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-62.2%WEAK▾
S&P3
ROA?-55.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-226249000
Enterprise Value?$2.7B
Fundamentals ratios updated end of day